Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis

Open access

Abstract

BACKGROUND: Inflammation is a common pathological phenomenon of osteoarthritis (OA). Accumulated evidence indicates that ameliorating or suppressing inflammation might be a promising and effective therapeutic strategy for the treatment of OA. Notably, glucagon-like peptide-1 (GLP-1)-based drugs are being successfully used to control glucose levels in patients with diabetes mellitus. In addition, recent findings have indicated that GLP-1 agonists, such as liraglutide have therapeutic potential in preventing inflammation-related disorders through the regulation of protein kinase A (PKA)/ cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) signals. Intra-articular injection of monoiodoacetate (MIA) has been widely used to induce OA. Thus, the present study aimed to investigate whether liraglutide has anti-inflammatory effects on MIA-induced OA rats and uncover its underlying molecular mechanisms. METHODS: Intra-articular injection of MIA was used to induce knee OA in a rat model. Subcutaneous injection of liraglutide was used to upregulate the expression of GLP-1 receptor (GLP-1R). Western blot analysis was utilized to measure the expression of GLP-1R, PKA/CREB pathway components and inflammation-related proteins, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and IL-6. Immunoprecipitation techniques were used to detect the interactions between GLP-1R and the PKA/CREB pathway. RESULTS: The levels of GLP-1R decreased significantly in the knees of OA rats, accompanied by the downregulation of PKA /CREB signals and upregulation of inflammation-related proteins. We also found that GLP-1R interacted with the PKA/CREB pathway and that liraglutide could activate PKA/CREB signals, thereby inhibiting the expression of inflammation-related proteins. CONCLUSIONS: Together our results suggest that liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway in an OA rat model.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12950-019-0218-y

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Decreased expression of GLP-1R in the cartilage tissues of a knee OA rat model. a Representative Western blots and quantification data of GLP-1R expression levels in control, OA-1, OA-5, OA-10, OA-20 and OA-28 groups (n = 5 per group). b Representative images (100 × and 200×) of immunohistochemical (IHC) staining and corresponding quantification of GLP-1R expression levels in the control and OA-28 groups (n = 5 per group). * indicates P < 0.05 compared with the control group
Fig. 1 Decreased expression of GLP-1R in the cartilage tissues of a knee OA rat model. a Representative Western blots and quantification data of GLP-1R expression levels in control, OA-1, OA-5, OA-10, OA-20 and OA-28 groups (n = 5 per group). b Representative images (100 × and 200×) of immunohistochemical (IHC) staining and corresponding quantification of GLP-1R expression levels in the control and OA-28 groups (n = 5 per group). * indicates P < 0.05 compared with the control groupCC BY · PubMed Central
Fig. 2 GLP-1R is associated with the PKA/CREB pathway in cartilage tissues of the knee OA rat model. a Representative Western blots of immunoprecipitates (n = 5 per group). b Representative Western blots and quantification data of PKA, p-PKA, CREB and p-CREB levels in control, OA-1, OA-5, OA-10, OA-20 and OA-28 groups (n = 5 per group). * indicates P < 0.05 when compared with the control group
Fig. 2 GLP-1R is associated with the PKA/CREB pathway in cartilage tissues of the knee OA rat model. a Representative Western blots of immunoprecipitates (n = 5 per group). b Representative Western blots and quantification data of PKA, p-PKA, CREB and p-CREB levels in control, OA-1, OA-5, OA-10, OA-20 and OA-28 groups (n = 5 per group). * indicates P < 0.05 when compared with the control groupCC BY · PubMed Central
Fig. 3 Induction of knee OA is accompanied by inflammation. Representative Western blots and quantification data for TNF-α, IL-6,and IL-1β expression levels in control, OA-1, OA-5, OA-10, OA-20 and OA-28 groups (n = 5 per group). * indicates P < 0.05 compared with the control group
Fig. 3 Induction of knee OA is accompanied by inflammation. Representative Western blots and quantification data for TNF-α, IL-6,and IL-1β expression levels in control, OA-1, OA-5, OA-10, OA-20 and OA-28 groups (n = 5 per group). * indicates P < 0.05 compared with the control groupCC BY · PubMed Central
Fig. 4 Liraglutide affects body weight and upregulates GLP-1R in the cartilage tissues of the knee OA rat mode. a Body weight of rats in the “OA”, “OA + saline” and “OA + liraglutide” groups at 0 day, 7th day, 14th day, 21st day and 28th day after treatment with liraglutide or saline (n = 5 per group). b Representative Western blots and quantification data of GLP-1R in the “OA”, “OA + saline” and “OA + liraglutide” groups (n = 5 per group). c Representative images (100 × and 200×) of IHC staining and corresponding quantification of GLP-1R levels in the “OA”, “OA + saline”, and the “OA + liraglutide” groups (n = 5 per group). * indicates P < 0.05 compared with the “OA + saline” group
Fig. 4 Liraglutide affects body weight and upregulates GLP-1R in the cartilage tissues of the knee OA rat mode. a Body weight of rats in the “OA”, “OA + saline” and “OA + liraglutide” groups at 0 day, 7th day, 14th day, 21st day and 28th day after treatment with liraglutide or saline (n = 5 per group). b Representative Western blots and quantification data of GLP-1R in the “OA”, “OA + saline” and “OA + liraglutide” groups (n = 5 per group). c Representative images (100 × and 200×) of IHC staining and corresponding quantification of GLP-1R levels in the “OA”, “OA + saline”, and the “OA + liraglutide” groups (n = 5 per group). * indicates P < 0.05 compared with the “OA + saline” groupCC BY · PubMed Central
Fig. 5 Liraglutide activates the PKA/CREB pathway in cartilage tissues of the knee OA rat model. Representative Western blots and quantification data of PKA, p-PKA, CREB and p-CREB in the “OA”, “OA + saline” and “OA + liraglutide” groups (n = 5 per group). * Indicates P < 0.05 compared with the “OA + saline” group
Fig. 5 Liraglutide activates the PKA/CREB pathway in cartilage tissues of the knee OA rat model. Representative Western blots and quantification data of PKA, p-PKA, CREB and p-CREB in the “OA”, “OA + saline” and “OA + liraglutide” groups (n = 5 per group). * Indicates P < 0.05 compared with the “OA + saline” groupCC BY · PubMed Central
Fig. 6 Liraglutide ameliorates inflammation in the knee OA rat model. Representative Western blots and quantification data for TNF-α, IL-6 and IL-1β in the “OA”, “OA + saline” and “OA + liraglutide” groups (n = 5 per group). * indicates P < 0.05 compared with the “OA + saline” group
Fig. 6 Liraglutide ameliorates inflammation in the knee OA rat model. Representative Western blots and quantification data for TNF-α, IL-6 and IL-1β in the “OA”, “OA + saline” and “OA + liraglutide” groups (n = 5 per group). * indicates P < 0.05 compared with the “OA + saline” groupCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 90

Metadata

Authors
Que, Q., Guo, X., Zhan, L., Chen, S., Zhang, Z., Ni, X., Ye, B., & Wan, S.
Affiliations
  • Lishui City People's Hospital (CN)
  • Sir Run Run Shaw Hospital (CN)
Corresponding author
Wan, Shuanglin
Venue
Journal of Inflammation
Published
2019-06-06
Volume
16
Issue
1
Pages
13-13
ISSN
1476-9255 (ISSN-L)
OpenAlex
W2948036374
Cited by
90
References
28
Citations by year
2026: 16 · 2025: 31 · 2024: 13 · 2023: 2 · 2022: 14 · 2021: 7 · 2020: 5 · 2019: 2
FWCI
5.31
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Inflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
liraglutide, knee osteoarthritis, GLP-1 receptor, PKA/CREB signaling, anti-inflammatory activity, monoiodoacetate-induced osteoarthritis, TNF-α, IL-1β, interleukin-6, GLP-1 receptor agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis. https://app.cochat.ai/papers/10.1186/s12950-019-0218-y
The paper
Que, Q., Guo, X., Zhan, L., Chen, S., Zhang, Z., Ni, X., Ye, B., & Wan, S. (2019). The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis. Journal of Inflammation. https://doi.org/10.1186/s12950-019-0218-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.